NASDAQ: KZR
Kezar Life Sciences Inc Stock Ownership - Who owns Kezar Life Sciences?

Insider buying vs selling

Have Kezar Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark C. SchillerChief Legal Officer2024-07-026,688$0.58
$3.88kSell

1 of 1

KZR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KZR insiders and whales buy or sell their stock.

KZR Shareholders

What type of owners hold Kezar Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Equal Talent Investments Ltd85.61%6,254,545$27.46MInsider
Morningside Venture Investments Ltd26.66%1,947,993$8.55MInsider
Cormorant Asset Management LP25.85%1,888,397$8.29MInsider
Omega Fund IV LP18.98%1,386,544$6.09MInsider
Onyx Therapeutics Inc15.35%1,121,384$4.92MInsider
Franklin M. Berger12.19%890,691$3.91MInsider
Tang Capital Management LLC9.86%720,000$3.16MInstitution
Suvretta Capital Management LLC9.81%716,759$3.15MInstitution
Bay City Capital LLC8.52%622,229$2.73MInsider
Avidity Partners Management LP6.88%502,600$2.21MInstitution

1 of 3

KZR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KZR20.93%79.07%Net Selling
KLRS14.79%85.21%Net SellingNet Selling
LVTX24.61%38.47%
CVKD0.19%99.81%
OKUR34.13%65.87%Net BuyingNet Selling

Kezar Life Sciences Stock Ownership FAQ

Who owns Kezar Life Sciences?

Kezar Life Sciences (NASDAQ: KZR) is owned by 57.55% institutional shareholders, 217.41% Kezar Life Sciences insiders, and 0.00% retail investors. Equal Talent Investments Ltd is the largest individual Kezar Life Sciences shareholder, owning 6.25M shares representing 85.61% of the company. Equal Talent Investments Ltd's Kezar Life Sciences shares are currently valued at $27.39M.

If you're new to stock investing, here's how to buy Kezar Life Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.